Tau as a Potential Novel Therapeutic Target in Ischemic Stroke

被引:30
|
作者
Zheng, Guo-Qing [1 ]
Wang, Xiu-Min [1 ]
Wang, Yan [1 ]
Wang, Xiao-Tong [1 ]
机构
[1] Second Affiliated Hosp, Wenzhou Med Coll, Ctr Neurol & Rehabil, Wenzhou 325027, Peoples R China
关键词
TAU PROTEINS; ISCHEMIC STROKE; THERAPEUTIC TARGET; CEREBRAL-ISCHEMIA; HUMAN BRAIN; PHOSPHORYLATION; RAT; HYPERPHOSPHORYLATION; REPERFUSION; DEPHOSPHORYLATION; OLIGODENDROCYTES; IMMUNOREACTIVITY; HIPPOCAMPUS;
D O I
10.1002/jcb.22408
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Stroke is associated with high mortality and major disability burdens worldwide, but there are few effective and widely available therapies. Tau plays an important role in promoting microtubule assembly and stabilizing microtubule networks with phosphorylation regulating these functions. Based on the "ischemic-reperfusion theory" of Alzheimer's disease, some previous studies have focused on the relationship of tau and Alzheimer lesions in experimental brain ischemia. Thus, we hypothesize that the alterations in phosphorylation of tau are critical to microtubule dynamics and metabolism, and contribute to the pathophysiologic mechanisms during brain ischemia and/or reperfusion processes. We infer that regulation of phosphorylation of tau may be considered as a potential new therapeutic target in ischemic stroke. J. Cell. Biochem. 109: 26-29, 2010. (C) 2009 Wiley-Liss, Inc.
引用
收藏
页码:26 / 29
页数:4
相关论文
共 50 条
  • [21] Trimethylamine-N-oxide: a potential biomarker and therapeutic target in ischemic stroke
    Liu, Yuan
    Qu, Juan
    Xu, Junjie
    Gu, Aiming
    Deng, Dezhi
    Jia, Xiaodan
    Wang, Baoxiang
    FRONTIERS IN NEUROLOGY, 2023, 14
  • [22] Kv1.3 Lymphocyte Potassium Channel Inhibition as a Potential Novel Therapeutic Target in Acute Ischemic Stroke
    Folyovich, Andras
    Biro, Eniko
    Orban, Csaba
    Bajnok, Anna
    Vasarhelyi, Barna
    Toldi, Gergely
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2014, 13 (05) : 801 - 806
  • [23] Detrimental and Beneficial Effect of Autophagy and a Potential Therapeutic Target after Ischemic Stroke
    Wang, Meng
    Lee, Hangil
    Elkin, Kenneth
    Bardhi, Redina
    Guan, Longfei
    Chandra, Ankush
    Geng, Xiaokun
    Ding, Yuchuan
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2020, 2020
  • [24] Blood pressure variability in subacute ischemic stroke A neglected potential therapeutic target
    Tsivgoulis, Georgios
    Ntaios, George
    NEUROLOGY, 2012, 79 (20) : 2014 - 2015
  • [25] Mitochondrial Quality and Quantity Control: Mitophagy Is a Potential Therapeutic Target for Ischemic Stroke
    Meiying Song
    Yuan Zhou
    Xiang Fan
    Molecular Neurobiology, 2022, 59 : 3110 - 3123
  • [26] Myogenic Tone as a Therapeutic Target for Ischemic Stroke
    Palomares, Sara M.
    Cipolla, Marilyn J.
    CURRENT VASCULAR PHARMACOLOGY, 2014, 12 (06) : 788 - 800
  • [27] PPAR-γ:: therapeutic target for ischemic stroke
    Culman, Juraj
    Zhao, Yi
    Gohlke, Peter
    Herdegen, Thomas
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2007, 28 (05) : 244 - 249
  • [28] Prospects of Therapeutic Target and Directions for Ischemic Stroke
    Kim, Jung Hak
    Kim, So Young
    Kim, Bokyung
    Lee, Sang Rae
    Cha, Sang Hoon
    Lee, Dong Seok
    Lee, Hong Jun
    PHARMACEUTICALS, 2021, 14 (04)
  • [29] Ischemic stroke - novel therapeutic strategies
    Farbu, E.
    Kurz, K. D.
    Kurz, M. W.
    ACTA NEUROLOGICA SCANDINAVICA, 2011, 124 : 28 - 37
  • [30] Ferroptosis: a potential therapeutic target for stroke
    Liu, Chengli
    Wang, Guijun
    Han, Wenrui
    Tian, Qi
    Li, Mingchang
    NEURAL REGENERATION RESEARCH, 2024, 19 (05) : 988 - 997